Ilyang Pharmaceutical Co.,Ltd (KRX:007570)

KRX:007570 Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 21, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	148,777	233,921	205,533	281,258	349,981	510,655
Market Cap Growth	-34.07%	13.81%	-26.92%	-19.64%	-31.46%	-57.37%
Enterprise Value	239,340	341,842	341,070	394,941	436,337	605,360
Last Close Price	8300.00	12895.00	11274.48	15257.93	18681.48	26877.80

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 21, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	8.41	34.77	22.76	-	18.49	36.39
Forward PE	-	49.90	49.90	49.90	49.90	49.90
PS Ratio	0.54	0.86	0.77	1.06	1.41	2.11
PB Ratio	0.58	0.97	0.86	1.22	1.47	2.25
P/TBV Ratio	0.59	1.00	0.88	1.26	1.51	2.32
P/FCF Ratio	5.25	36.99	-	32.19	180.62	13.07
P/OCF Ratio	4.31	19.43	36.60	19.24	59.49	9.93

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 21, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
EV/Sales Ratio	0.86	1.25	1.27	1.48	1.76	2.50
EV/EBITDA Ratio	-	25.69	17.54	13.93	16.77	22.92
EV/EBIT Ratio	-	68.88	35.45	24.11	30.62	39.86
EV/FCF Ratio	8.45	54.06	-	45.21	225.19	15.50

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 21, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Debt / Equity Ratio	0.44	0.53	0.45	0.32	0.31	0.43
Debt / EBITDA Ratio	44.46	9.53	5.54	2.56	2.85	3.73
Debt / FCF Ratio	2.98	20.05	-	8.32	38.24	2.52
Net Debt / Equity Ratio	0.28	0.40	0.40	0.26	0.26	0.24
Net Debt / EBITDA Ratio	28.81	7.30	4.88	2.08	2.36	2.08
Net Debt / FCF Ratio	1.93	15.37	-2.91	6.75	31.75	1.41
Asset Turnover	0.61	0.61	0.65	0.67	0.60	0.56
Inventory Turnover	2.57	2.52	2.79	2.96	3.46	3.40
Quick Ratio	0.52	0.46	0.39	0.47	0.46	0.59
Current Ratio	0.93	0.86	0.80	0.89	0.82	0.81
Return on Equity (ROE)	8.13%	2.97%	3.95%	-0.87%	8.53%	6.25%
Return on Assets (ROA)	-0.80%	0.70%	1.46%	2.57%	2.17%	2.21%
Return on Invested Capital (ROIC)	-1.26%	0.79%	2.63%	5.56%	4.07%	3.45%
Return on Capital Employed (ROCE)	-1.90%	1.70%	3.50%	6.50%	5.50%	6.00%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 21, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Earnings Yield	11.50%	2.95%	4.39%	-0.86%	5.54%	2.75%
FCF Yield	19.04%	2.70%	-15.85%	3.11%	0.55%	7.65%
Dividend Yield	1.86%	-	-	0.98%	-	-
Payout Ratio	18.86%	41.72%	32.93%	-	20.34%	16.74%
Buyback Yield / Dilution	7.05%	2.63%	-2.29%	0.59%	0.44%	-
Total Shareholder Return	8.91%	2.63%	-2.29%	1.57%	0.44%	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 21, 2026

Data Sources Report a data error